Joseph N. DiStefano writes about Philadelphia-area enterprise, and the people and money that make it go.

Latest Stories

More ex-Wilmington Trust bankers sentenced to prison

Two more bankers at what was once the Philadelphia area's largest locally-based bank were sentenced to federal prison for lying about massive loan losses.


Jack Bogle was a cheerful pessimist, a master salesman, Vanguard’s builder and voice

Bogle's frank, disarming, cheerful style made people believe that they could understand money and time.

MLK event canceled at Philly’s shuttered Liberty Bell due to shutdown; corporate rescue runs out of time

A last-minute appeal to corporations and charities to reopen the Liberty Bell for scheduled Martin Luther King Day activities has fallen short. Each day Independence National Historic Park is closed costs businesses and the city’s tax collections an estimated $1 million

They’re hiring: Philly investment firm 1315 Capital makes a big bet on Biocoat, maker of coatings for medical devices

Philly's fast-growing 1315 Capital has invested at least $10 million in Horsham-based Biocoat, which makes coatings for medical devices inserted in people

Financial services firm Univest is bringing back an old Philadelphia name to capitalize on the brand

The change was prompted by how Girard Partners has gained clients and assets despite harsh conditions for registered investment advisers its size.

Raymond G. Perelman, master investor and philanthropist, dies at 101

He was a master businessman who bought and sold companies with abandon. He also became one of the Philadelphia region’s greatest philanthropists, leaving his mark at the University of Pennsylvania and beyond.

A Philadelphia digital pioneer from the ’60s will be its newest public company on NYSE

One of Philly's oldest computer-age businesses will be its newest public company as Clarivate's owners list it on the New York Stock Exchange this Spring.

King of Prussia firm strikes national deal to sell plant-based egg substitute

Renmatix, based in King of Prussia, has found a global distributor for its Simple Cellulose vegan egg substitute.

These two Philly medical stocks doubled investors’ money in 2018

Tabula Rasa Healthcare, the Moorestown-based drug-delivery software firm, and BioTelemetry, the Malvern heart-monitor maker, ranked among the top 10 for share-price gains among the Standard & Poor’s index of 600 small-cap stocks in 2018.

In two more weeks, cost of shutdown could exceed what Trump wants for the wall

“It will only take another two weeks to cost the U.S. economy more than the $5.7 billion that the White House requested for the border wall,” S&P said in a statement.